Search

everythinglearnresearchcommunity

for

Search:↓

Prednisone reduces organ mast cell infiltration but does not alter the abnormal appearance of mast cells in systemic mastocytosis.

A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.

Cyclosporin doesn't stop hair loss.

Alopecia patients have more mast cells in their scalps, especially in severe cases and older age, with alopecia areata showing the highest increase.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Experts don't fully agree on how to diagnose certain hair growth disorders and more research is needed to understand them better.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

A sugar glider had a rare skin cancer that worsened despite treatment, highlighting the need for thorough checks in exotic pets.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

People with Alopecia Areata and Androgenic Alopecia have more mast cells in their scalp than healthy individuals, especially those with Alopecia Areata.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Frontal fibrosing alopecia is linked to hypothyroidism but doesn't affect quality of life.

Clinical signs don't match inflammation levels in lichen planopilaris and frontal fibrosing alopecia.

Blood count parameters are not reliable for predicting recurrent implantation failure.

The steroid solution can regrow hair but often causes skin issues and doesn't work long-term.

Cavity macrophages gather on organ surfaces but don't really invade or help repair the organs after injury.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Platelet-rich plasma (PRP) may help treat hair loss in patients with frontal fibrosing alopecia who don't respond to other treatments.

A rare skin rash after COVID-19 vaccination shouldn't stop future vaccinations.

Reassurance is important for postpartum hair shedding as it likely won't cause complete baldness.

A woman with a unique syndrome similar to TRPS has a genetic change near the TRPS1 gene, affecting its regulation.

Trichoscopy helps diagnose hair and scalp problems but isn't always definitive and should be used with other methods.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Hair loss in Cronkhite-Canada syndrome is reversible by treating the gut issues and doesn't need steroid treatment for the hair itself.

A man with rare Lichen Planopilaris lost body hair, not scalp hair, and treatment stopped itching but didn't regrow hair.

The document says homoeopathic treatments are good for hair regrowth in alopecia areata but doesn't give proof.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.